AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Byline: GLORIA LAU
You could say Ron Tydings is becoming an expert on Alzheimer's disease.
His wife of 41 years, Barrie, is in the late-middle stages of Alzheimer's after being diagnosed with the disease six years ago.
Based on her increasing forgetfulness and other changes in her behavior, Ron says he suspects the dementia started as early as January 1993.
"It was unlike her to ask me the same question three times in two minutes," said Ron, 63 a banking attorney in Fairfax, Va. "She still knows me and family and friends, though she can't always recall a name."
After Barrie's initial diagnosis, a doctor prescribed Pfizer Inc.'s Aricept, the world's top selling Alzhei-mer's drug with a 67% share of the $1 billion a year market. Barrie took that for three years.
A second doctor switched her to Johnson & Johnson's Reminyl, which has an estimated 10% of the market.